An FIR was launched against some unidentified persons for cheating the Serum Institute of India for more than Rs 1 crore, said the officials
Besides Bharat Biotech's nasal vaccine, India has 13 vaccines to fight against Covid-19. Two have been approved for manufacturing, while 11 have been approved for emergency use
The petitioner is Dilip Lunawat, who has contended that his daughter Snehal Lunawat, 33, who was also a Senior Lecturer at the SMBT Dental College in Nashik, was compelled to take the vaccine
Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices
South Africa's Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa
Serum Institute of India CEO Adar Poonawalla on Tuesday called on Prime Minister Narendra Modi and congratulated him for his leadership in the fight against the COVID-19 pandemic. In a tweet, Poonawalla said he met Modi on Tuesday. "Delighted to have met PM, Shri @narendramodi Ji. Congratulated him for his remarkable leadership and success in the fight against COVID-19. As an entrepreneur, I find his commitment to reforms, social welfare, and vision for Aatmanirbhar Bharat very assuring," he tweeted. Pune-based Serum Institute of India is the world's largest company in terms of COVID-19 vaccine production.
Indian Immunologicals, and Haffkine Research Institute also in the fray
Among the companies that are working with ICMR are Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy's Laboratories, and Biological E
SII is building a future pandemic facility, which will have an annual capacity of 2 bn doses
SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases
Some are 'Midnight's Children' whose pre-Independence businesses bloomed after 1947, some 'Licence Raj Warriors' who refused to let red-tapeism slow them down. A look at 25 towering business leaders
The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems
Are Indian start-ups on a road to profitability? What is keeping Adar Poonawalla busy these days? Is the current strength in rupee sustainable? What is an Encumbrance Certificate? All answers here
Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more
80-90% of our global capacity will be in India, says SII CEO Adar Poonawalla
The government on late Tuesday increased the windfall tax on domestically produced crude to Rs 17,750 a tonne from Rs 17,000 a tonne earlier
Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month
Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan here on Tuesday.
"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation
India has reported four cases monkeypox, including three in Kerala, so far